Alpha 2.0
Login Register
» Authors » Stephen Shiboski

Stephen Shiboski

Explore the profile of Stephen Shiboski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 2337
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Public Health
Top 10 Co-Authors
Anna-Barbara Moscicki
Craig R Cohen
Yifei Ma
Gabriela Schmajuk
Jinoos Yazdany
Sepideh Farhat
Tsungai Chipato
Judith A Hahn
Ariane van der Straten
Laura Trupin
Published In
PLoS One
Sex Transm Dis
J Infect Dis
AIDS
J Acquir Immune Defic Syndr
Affiliations
Soon will be listed here.
Recent Articles
1.
Drivers of infliximab biosimilar uptake: A comparative analysis of new biosimilar initiations versus switching in a national rheumatology registry
Roberts E, Bansback N, Tseng C, Shiboski S, Li J, Schmajuk G, et al.
Health Serv Res . 2024 Dec; PMID: 39618177
Objective: To analyze the variability in new infliximab biosimilar starts as well as switching from bio-originator to biosimilar infliximab, across insurance payers and rheumatology practices nationally. Study Setting And Design:...
2.
Correction to: Limited English proficiency is associated with access barriers to isotretinoin for acne
Choe J, Yan A, Charrow A, Mostaghimi A, Shiboski S, Chang A, et al.
Arch Dermatol Res . 2024 Nov; 317(1):11. PMID: 39520574
No abstract available.
3.
National rollout of a medication safety dashboard to improve testing for latent infections among biologic and targeted synthetic disease-modifying agent users within the Veterans Health Administration
Schmajuk G, Ware A, Li J, Tarasovsky G, Shiboski S, Barton J, et al.
Health Serv Res . 2024 Jul; 60(1):e14363. PMID: 39056425
Objective: To develop, deploy, and evaluate a national, electronic health record (EHR)-based dashboard to support safe prescribing of biologic and targeted synthetic disease-modifying agents (b/tsDMARDs) in the United States Veterans...
4.
"We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine." Factors influencing the choice of safer conception methods and experiences with its use: a qualitative study among HIV sero-discordant couples...
Brown J, Musara P, Gitome S, Chitukuta M, Mataveke B, Chirenda T, et al.
BMC Public Health . 2024 Jul; 24(1):1936. PMID: 39030487
Background: Safer conception services are needed to minimize HIV transmission among HIV sero-discordant couples desiring pregnancy. Few studies have evaluated the choices couples make when they are offered multiple safer...
5.
"". A qualitative study on safer conception decision-making among HIV sero-different couples in Zimbabwe
Gitome S, Musara P, Chitukuta M, Mhlanga F, Mateveke B, Chirenda T, et al.
Sex Reprod Health Matters . 2024 Jul; 32(1):2366587. PMID: 39007699
Decision-making on childbearing and safer conception use in HIV sero-different couples involves an intricate balance of individual desires and perceived HIV acquisition risk. This paper addresses an important knowledge gap...
6.
Limited English proficiency is associated with access barriers to isotretinoin for acne
Choe J, Yan A, Charrow A, Mostaghimi A, Shiboski S, Chang A, et al.
Arch Dermatol Res . 2024 Jul; 316(7):464. PMID: 38990267
No abstract available.
7.
The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice
Yazdany J, Shiboski S, Schmajuk G
Arthritis Rheumatol . 2024 Jun; 76(10):1467-1470. PMID: 38923852
No abstract available.
8.
Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus
Aguirre A, DeQuattro K, Shiboski S, Katz P, Greenlund K, Barbour K, et al.
J Rheumatol . 2023 Jun; 50(10):1302-1309. PMID: 37321640
Objective: Concerns about the affordability of medications are common in systemic lupus erythematosus (SLE), but the relationship between medication cost concerns and health outcomes is poorly understood. We assessed the...
9.
An Electronic Dashboard to Improve Dosing of Hydroxychloroquine Within the Veterans Health Care System: Time Series Analysis
Montgomery A, Tarasovsky G, Izadi Z, Shiboski S, Whooley M, Dana J, et al.
JMIR Med Inform . 2023 May; 11:e44455. PMID: 37171858
Background: Hydroxychloroquine (HCQ) is commonly used for patients with autoimmune conditions. Long-term use of HCQ can cause retinal toxicity, but this risk can be reduced if high doses are avoided....
10.
Spirometry in Mixed-Race Civil War Veterans
Baugh A, Woodruff P, Shiboski S, Glidden D, Ortega V, Thakur N
Ann Am Thorac Soc . 2023 May; 20(8):1217-1219. PMID: 37159952
No abstract available.